Filing Details

Accession Number:
0000899243-19-005262
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-28 17:05:19
Reporting Period:
2019-02-26
Accepted Time:
2019-02-28 17:05:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754122 Volker Knappertz Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-02-26 8,436 $0.00 16,608 No 4 M Direct
Ordinary Shares Disposition 2019-02-26 504 $12.44 16,104 No 4 S Direct
Ordinary Shares Disposition 2019-02-26 3,600 $12.46 12,504 No 4 S Direct
Ordinary Shares Disposition 2019-02-26 36 $12.29 12,468 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2019-02-26 8,436 $0.00 8,436 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6 2019-02-26 2020-03-15 No 4 M Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into 703 American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019.
  3. These ordinary shares are represented by ADSs.
  4. The price reported in Column 4 is price per ordinary share converted from price per ADS.